英文名稱 Anti-phospho-ATF4 (Ser245)/FITC

中文名稱 :FITC標(biāo)記的磷酸化活化轉(zhuǎn)錄因子4抗體

規(guī)格:100ul

說明書 100ul  

產(chǎn)品類型磷酸化抗體

研究領(lǐng)域腫瘤  細(xì)胞生物  免疫學(xué)  信號轉(zhuǎn)導(dǎo)  細(xì)胞凋亡  轉(zhuǎn)錄調(diào)節(jié)因子  

抗體來源Rabbit

克隆類型Polyclonal

交叉反應(yīng) Human,

產(chǎn)品應(yīng)用IF=1:50-200  

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分子量38kDa

細(xì)胞定位細(xì)胞膜

性    狀Lyophilized or Liquid

濃    度1mg/ml

免疫原KLH conjugated Synthesised phosphopeptide derived from human ATF4 around the phosphorylation site of Ser245

亞    型IgG

純化方法affinity purified by Protein A

儲存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件Store at -20 °C for one year.

別　名　ATF4 (phospho S245); ATF4(Phospho-Ser245); Cyclic AMP response element binding protein 2; DNA binding protein TAXREB67; Activating Transcription Factor 4; ATF 4; ATF4 protein; CREB 2; CREB2; CREB-2; Cyclic AMP dependent transcription factor ATF 4; Tax Responsive Enhancer Element B67; TAXREB67; TXREB; ATF4_HUMAN.